Using genome sequencing & machine learning to modernize infectious disease diagnosis and treatment
Antibiotic resistance is creating a public health crisis. Patients with a severe infection can die within hours, but current diagnostics for antibiotic resistance take 2 days or longer. At DZD, we are developing a rapid, whole genome sequencing-based diagnostic that identifies the strain and antibiotic resistance profile of a bacterial infection within hours. We are located at the Pagliuca Harvard Life Lab and Harvard iLab and we have a strong collaboration with the lab of Dr. Doug Kwon at the Ragon Institute of MGH, MIT and Harvard.
President & CEO, Co-founder
Founder at Incyte Medical Consulting, SVP Marketing & Strategy at ConforMIS, Management Consultant at Monitor Group. Studied at Harvard '93, Harvard Business School '99.
Clinical Lead, Co-founder
Infectious Disease physician at Mass. General Hospital. Assistant Professor at Harvard Medical School. Director of Clinical Research at Ragon Institute of MGH, MIT and Harvard. Studied at Harvard '93, NYU '04 MD, PhD.
Biomedical Lead, Co-founder
Clinical Pathology resident at Mass. General Hospital. Studied at MIT '08, Oxford '09, Harvard '15 PhD and Harvard-MIT HST '17 MD. Rhodes Scholar, Soros Fellow, MSTP Fellow.
Genomics Lead, Co-founder
Studied at MIT '09, Harvard '16. PhD in Applied Math focused on computational approaches to genomic analysis in complex biological systems. NSF GRFP Fellow.
Software Lead, Co-founder
Studied at U. of Melbourne '08, '10, Harvard '16. PhD focused on machine learning as part of Harvard Intelligent Probabilistic Systems group. Frank Knox Fellow.
University of California, Berkeley, '03. B.S. Molecular Environmental Biology. Managed Sequencing Core at Universtiy of Alaska, Fairbanks.
University of Virginia, '16 B.A, '17 M.P.H.
DZD Announces Completion of $3M Series Seed Raise
Funding to support completion of technical proof of concept and prototype development
The New World Order Of Artificial Intelligence
DZD highlighted in Forbes article on AI trends
MedTech Innovator Announces Startups Selected for Global Accelerator
DZD one of 20 participants in the industry's premier accelerator
MassChallenge Boston Announces 2017 Accelerator Cohort
DZD selected from over 1,500 applicants to participate in program
Finalists Named in Harvard President's Innovation Challenge
DZD named one of 5 healthcare finalists in innovation challenge
Harvard Innovation Labs Story: Miriam Huntley
Miriam interviewed on the Harvard Innovation Labs podcast
Life Lab Builds on Cross-disciplinary Approach
Day Zero Diagnostics featured in opening ceremony of the Pagliuca Harvard Life Lab
Kwon Awarded MGH DOM Innovation Grant
The Kwon Lab wins innovation grant to pursue bacterial resistance diagnostics
Here Are 8 Digital Health Startups to Watch in Boston
BostInno features Day Zero Diagnostics as a startup to watch
Day Zero Diagnostics Named 2016 HBSAB New Venture Competition Winner
DZD wins Harvard Business School Association of Boston Alumni New Venture Contest
Winner, New England Region (2016)
Winner, Pilot Innovation Grant (2016)
Venture in Residence, Harvard iLab & Life Lab (2016-2017)
Audience Choice, MIT Sloan Healthcare Innovation Prize (2017)
Winner, Boston Pitch Competition (2017), MedTech Innovator Accelerator (2017)
Finalist, Harvard President's Innovation Challenge (2017)
Finalist, MassChallenge Accelerator Program (2017)
Harvard Innovation Lab, Batten Hall, 125 Western Ave, Allston, MA 02163
Copyright © 2017 Day Zero Diagnostics Inc.